Search Results

« Previous 12345 Next »
Viewing Page 1 of 25 | Showing Results 1 - 10 of 249

Enroll-HD: A Prospective Registry Study in a Global Huntington’s Disease Cohort

Neal Hermanowicz, MD
UC Irvine

Coenzyme Q10 (CoQ) in Huntington’s disease (2CARE)

Neal Hermanowicz, MD
UC Irvine

An open-label, multicenter, study to evaluate the safety, tolerability pharmacodynamics, and pharmacokinetics of three dosing regimens of oral AT2220 in patients with Pompe disease

Tahseen Mozaffar, MD
UC Irvine ALS and Neuromuscular Center, 200 South Manchester Avenue, Ste. 110, Orange CA 92868 (Manchester Pavilion)

A randomized, double-blind, placebo-controlled, cross-over, multi-center study of Eculizumab in patients with general myasthenia gravis (gMG) who have moderate to severe muscle weakness despite treatment with immunosuppressants

Tahseen Mozaffar, MD
UC Irvine ALS and Neuromuscular Center, 200 South Manchester Avenue, Ste. 110, Orange CA 92868 (Manchester Pavilion)

Immunomodulation by Oral N-acetylglucosamine

Michael Demetriou, MD, PhD, FRCP(C)
ICTS (Hewitt Hall) and Gottschalk Medical Plaza (both on the UC Irvine main campus), as well as UC Irvine Medical Center.
Accepting Participants
« Previous 12345 Next »